Name:
Pandoraea fibrosis See-Too et al. 2019
DSM No.:
103228, Type strain dsm-103228 dsm103228 dsm 103228 Pandoraea fibrosis
Isolated from:
sputumof cystic fibrosis patient
Country:
Australia
Tasmania
Date of sampling:
02.2012
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- R. Ee, Univ. of Malaya, Kuala Lumpur, Malaysia; 6399 <- Royal Hobart Hospital, Dept. of Microbiology staff, Tasmania, Australia
Genbank accession numbers:
Summary and
additional information:
<- R. Ee, Univ. of Malaya, Kuala Lumpur, Malaysia; 6399 <- Royal Hobart Hospital, Dept. of Microbiology staff, Tasmania, Australia. Sputumof cystic fibrosis patient. Australia, Tasmania. Sampling Date: before 29.02.2012. Sequence accession no. 16S rRNA gene: KX712083. (Medium 535, incubation time: 1-2 days, pH 7, 37°C, aerobic)
Risk group:
2 (provisional classification by DSMZ)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
